Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1999-02-26
2000-09-05
McKelvey, Terry
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
A61K 3170
Patent
active
061143111
ABSTRACT:
Disclosed is a smooth muscle cell specific promoter, the SM22.alpha. gene promoter as well as the murine cDNA and genomic SM22.alpha. nucleic acid sequences. Also disclosed are methods of preventing restenosis following balloon angioplasty and methods of treating asthma based on inhibition of smooth muscle cell proliferation by expressing cell cycle control genes, or contraction inhibiting peptides in smooth muscle cells, under the control of the SM22.alpha. promoter.
REFERENCES:
patent: 5837534 (1998-11-01), Olson et al.
Orkin et al, Report and Recommendations of the Panel to Assess the NIH Investments in Research on Gene Therapy, issued by the National Institutes of Heath, unnumbered pages, Dec. 7, 1995.
Verma et al, Nature, vol. 389, pp. 239-242, Sep. 18, 1997.
Anderson, Nature, vol. 392, Supplement, pp. 25-30, Apr. 30, 1998.
Aikawa et al., "Human Smooth Muscle Myosin Heavy Chain Isoforms as Molecular Markers for Vascular Development and Atherosclerosis," Circulation Research, 73(6):1000-1012, Dec. 1993.
Akira et al., "A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family," The EMBO Journal, 9(6):1897-1906, 1990.
Blank et al., "Elements of the Smooth Muscle .beta.-Action Promoter Required in Cis for Transcriptional Activation in Smooth Muscle," J. of Biol. Chem., 267(2):984-989, Jan. 1992.
Carroll et al., "Structure and Complete Nucleotide Sequence of the Chicken .alpha.-Smooth Muscle (Aortic) Actin Gene," J. of Biol. Chem., 261(19):8965-8976, Jul. 1986.
Chang et al., "Cytostatic Gene Therapy for Vascular Proliferative Disorders with a Constitutively Active Form of the Retinoblastoma Gene Product," Science, 267:518-522, Jan. 1995.
Cserjesi et al., "MHox: a mesodermally restricted homeodomain protein that binds an essential site in the muscle creatine kinase enhancer," Development, 115:1087-1101, 1992.
Dalton and Treisman, "Characterization of SAP-1, a Protein Recruited by Serum Response Factor to the c-fos Serum Response Element," Cell, 68:597-612, Feb. 1992.
Devlin et al., "Identification of a Muscle-specific Enhancer within the 5'-Flanking Region of the Human Myoglobin Gene," J. of Biol. Chem., 264(23):13896-13901, Aug. 1989.
Dierks et al., "Three Regions Upstream from the Cap Site are Required for Efficient and Accurate Transcription of the Rabbit .beta.-Globin Gene in Mouse 3T6 Cells," Cell, 32:695-706, Mar. 1983.
Dynan and Tjian, "The Promoter-Specific Transcription Factor Sp 1 Binds to Upstream Sequences in the SV40 Early Promoter," Cell, 35:79-87, Nov. 1983.
Edmondson et al., "Analysis of the Myogenin Promoter Reveals in Indirect Pathway for Positive Autoregulation Mediated by the Muscle-Specific Enhancer Factor MEF-2," Mol. and Cell. Biol. USA, 12(9):3665-3677, Sep. 1992.
Evans et al., "An erythrocyte-specific DNA-binding factor recognizes a regulatory sequence common to all chicken globin genes," Proc. Natl. Acad. Sci., 85:5976-5980, Aug. 1988.
Fields and Song, "A novel genetic system to detect protein-protein interactions," Nature, 340:245-246, Jul. 1989.
Forrester et al., "A Paradigm for Restenosis Based on Cell Biology: Clues for the Development of New Preventive Therapies," JACC, 17(3):758-769, Mar. 1991.
Frid et al., "Myosin Heavy-Chain Isoform Composition and Disribution in Developing and Adult Human Aortic Smooth Muscle," J. Vasc. Res., 30:279-292, 1993.
Gimona et al., "Smooth muscle specific expression of calponin," FEBS, 274(1,2):159-162, Nov. 1990.
Gorski et al., "Molecular Cloning of a Diverged Homeobox Gene That is Rapidly Down-Regulated during the G.sub.0 /G.sub.1 Transition in Vascular Smooth Muscle Cells," Mol. and Cell. Biol., 13(6):3722-3733, Jun. 1993.
Gossett et al., "A New Myocyte-Specific Enhancer-Binding Factor That Recognizes a Conserved Element Associated with Multiple Muscle-Specific Genes.," Mol. and Cell. Biol., 9(11):5022-5033, Nov. 1989.
Gottesdiener et al., "Isolation and Structural Characterization of the Human 4F2 Heavy-Chain Gene, and Inducible Gene Involved in T-Lymphocyte Activation," Mol. and Cell. Biol., 8(9):3809-3819, Sep. 1988.
Grepin et al., "A Hormone-Encoding Gene Identifies a Pathway for Cardiac but Not Skeletal Muscle Gene Transcription," Mol. and Cell. Biol., 14(5):3115-3129, May 1994.
Grueneberg et al., "Human and Drosophila Homoedomain Proteins That Enhance the DNA-Binding Activity of Serum Response Factor," Science, 257:1089-1095, Aug. 1992.
Gustafson et al., "Interaction of Nuclear Proteins with Muscle-Specific Regulatory Sequences of the Human Cardiac .alpha.-Actin Promoter," Mol. and Cell. Biol., 8(10):4110-4119, Oct. 1988.
Gualberto et al., "Functional Antagonism Between YYI and the Serum Response Factor," Mol. and Cell. Biol., 12(9):4209-4214, Sep. 1992.
Hasty et al., "Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene," Nature, 364:501-506, Aug. 1993.
Ip et al., "The GATA-4 Transcription Factor Transactivates the Cardiac Muscle-Specific Troponin C Promoter-Enhancer in Nonmuscle Cells," Mol. and Cell. Biol., 14(11):7517-7526, Nov. 1994.
Jones et al., "A Cellular DNA-Binding Protein That Activates Eukaryotic Transcription and DNA Replication," Cell, 48:79-89, Jan. 1987.
Jaynes et al., "The Muscle Creatine Kinase Gene is Regulated by Multiple Upstream Elements, Including a Muscle-Specific Enhancer," Mol. and Cell. Biol., 8(1):62-70, Jan. 1988.
Johansen and Prywes, "Serum response factor: transcriptional regulation of genes induced by growth factors and differentiation," Biochimica et Biophysica Acta, 1242, 1-10, 1995.
Kadonaga and Tjian, "Affinity purification of sequence-specific DNA binding proteins," Proc. Natl., Acad. Sci. USA, 83:5889-5893, Aug. 1986.
Kretsinger, "Structure and Evolution of Calcium-Modulated Proteins," Critical Reviews in Biochemistry, CRC Press, 8(1):119-174, Jul. 1980.
Lassar et al., "MyoD is a Sequence-Specific DNA Binding Protein Requiring a Region of myc Homology to Bind to the Muscle Creatine Kinase Enhancer," Cell, 58:823-831, Sep. 1989.
Lee et al., "Displacement of BrdUrd-induced YY1 by serum response factor activates skeletal .alpha.-actin transcription in embryonic myoblasts," Proc. Natl. Acad. Sci. USA, 89:9814-9818, Oct. 1992.
Lees-Miller et al., "Isolation and Characterization of an Abundant and Novel 22-kDa Protein (SM22) from Chicken Gizzard Smooth Muscle," J. of Biol. Chem., 262(7):2988-2993, Mar. 1987.
Lilly et al., "Requirement of MADS Domain Transcription Factor D-MEF2 for Muscle Formation in Drosophila," Science, 267:688-693, Feb. 1995.
Liu et al., "Restenosis After Coronary Angioplasty, Potential Biologic Determinants and Role of Intimal Hyperplasia," Circulation, 79(6):1374-1387, Jun. 1989.
Martin, et al., "The paired-like homeo box gene MHox is required for early events of skeletogenesis in multiple lineages," Genes & Development, 9:1237-1249, 1995.
Miano et al., "Smooth Muscle Myosin Heavy Chain Exclusively Marks the Smooth Muscle Lineage During Mouse Embryogenesis," Circulation Research, 75(5):803-812, Nov. 1994.
Min et al., "The 5'-Flanking Region of the Mouse Vascular Smooth Muscle .alpha.-Actin Gene Contains Evolutionarily Conserved Sequence Motifs within a Functional Promoter," J. of Biol. Chem., 265(27):16667-16675, Sep. 1990.
Minty and Kedes, "Upstream Regions of the Human Cardiac Actin Gene That Modulate its Transcription in Muscle Cells: Presence of an Evolutionarily Conserved Repeated Motif," Mol. and Cell. Biol., 6(6):2125-2136, Jun. 1986.
Mitchell et al., "Positive and Negative Regulation of Transcription In Vitro: Enhancer-Binding Protein AP-2 is Inhibited by SV40 T Antigen," Cell, 50:847-861, Sep. 1987.
Natesan and Gilman, "DNA bending and orientation-dependent function of YY1 in the c-fos promoter," Genes & Development, 7:2497-2509, 1993.
Nishida et al., "cDNA cloning and mRNA expression of calponin and SM22 in rat aorta smooth muslce cells," Gene, 130:297-302, 1993.
Olson, "MyoD family: a paradigm for development?", Genes & Development, 4:1454-1461, 1990.
Orkin, "GATA-Binding Transcription Factors in Hematopoietic Cells," Blood, 80(3):575-581, Aug. 1992.
Owens et al., "Expression of Smooth M
Parmacek Michael S.
Solway Julian
ARCH Development Corporation
McKelvey Terry
LandOfFree
Method for modulating smooth muscle cell proliferation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for modulating smooth muscle cell proliferation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for modulating smooth muscle cell proliferation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2212250